DEVELOPMENT OF THE EMULGE LFOR THE ANDROGENIC ALOPECIA TREATMENT
Abstract
Androgenic alopecia (AGA) is the most common alopecia that is heritable, androgen-dependent and occurs in both sexes with defined patterns such as Male pattern hair loss in men and Female pattern hair loss in women. AGA affects at least 50 % of men by the age of 50 years, and up to 70 % of all males in later life.
The aim.The research was aimed to substantiate the optimal concentration of excipients and active pharmaceutical ingredients (APIs) of the emulgel intended for the topical treatment of androgenic alopecia.
Materials and methods. In this study the samples of the emulgel bases containing different carbomer Ultrez10 concentrationsin the range of 0.3–0.6 % and its neutralizers (0.1 % of potassium sorbate and 0 % or 0.2 % of triethanolamine) were used. Colloidal and thermal stability, pH, rheological properties (structural viscosity, mechanical stability, degree of thixotropy) of these samples were determined. The emulgel samples with different percentages of the Serenoa repens dry extract and the Sophora japonica tincture were used in the biopharmaceutical studies. The samples of the emulgel with the antioxidant butylhydroxytoluene different concentrations (0 %, 0.01 %, 0.02 %, 0.03 %) were used to determine acid value during 1 year of the emulgel storage.
Results and discussion. It was experimentally substantiated the optimal ratio of the emulgel ingredients that provide good APIs release and necessary consumer properties of the semi-solid remedy like application compliance, safety and storage stability.
Conclusions. Physicochemical, rheological and biopharmaceutical properties of emulgel bases have been studied. It was found that the base №2 (in which the concentrations of Carbomer Ultraz 10, potassium sorbate and triethanolamine are 0.3 %, 0.1 %, 0.2 % respectively) possessed the optimal properties. Considering the results of the complete range of experimental research it was developed the final formulation of the emulgel intended for AGA treatment which included the concentration of the APIs, neutralizers, preservatives, antioxidant and fragrance.
Downloads
References
Sanclemente, G., Burgos, C., Nova, J., Hernández, F., González, C., Reyes, M. I. et. al. (2017). The impact of skin diseases on quality of life: A multicenter study. Actas Dermo-Sifiliográficas, 108 (3), 244–252. doi: http://doi.org/10.1016/j.ad.2016.11.008
Schmitt, J. V., Ribeiro, C. F., Souza, F. H. de M. de, Siqueira, E. B. D., Bebber, F. R. L. (2012). Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic. Anais Brasileiros de Dermatologia, 87 (3), 412–417. doi: http://doi.org/10.1590/s0365-05962012000300010
França, K., Rodrigues, T. S., Ledon, J., Savas, J., Chacon, A. (2013). Comprehensive Overview and Treatment Update on Hair Loss. Journal of Cosmetics, Dermatological Sciences and Applications, 3 (3), 1–8. doi: http://doi.org/10.4236/jcdsa.2013.33a1001
Gordon, K. A., Tosti, A. (2011). Alopecia: evaluation and treatment. Clinical, Cosmetic and Investigational Dermatology, 4, 101–106. doi: http://doi.org/10.2147/ccid.s10182
Ramos, P. M., Miot, H. A. (2015). Female Pattern Hair Loss: a clinical and pathophysiological review. Anais Brasileiros de Dermatologia, 90 (4), 529–543. doi: http://doi.org/10.1590/abd1806-4841.20153370
Patel, S., Sharma, V., Chauhan, N., Thakur, M., Dixit, V. K. (2015). Hair Growth: Focus on Herbal Therapeutic Agent. Current Drug Discovery Technologies, 12 (1), 21–42. doi: http://doi.org/10.2174/1570163812666150610115055
Sonthalia, S., Daulatabad, D., Tosti, A. (2016). Hair restoration in androgenetic alopecia: looking beyond minoxidil, finasteride and hair transplantation. Journal of Cosmetology and Trichology, 2. doi: http://doi.org/10.4172/2471-9323.1000105
Dawid-Pać, R., Urbańska, M., Dębosz, I., Nowak, G. (2014). Plants as potential active components in treatment of androgenetic alopecia. Herba Polonica, 60 (1), 49–56. doi: http://doi.org/10.2478/hepo-2014-0005
Rossi, A., Mari, E., Scarnò, M., Garelli, V., Maxia, C., Scali, E. et. al. (2012). Comparitive Effectiveness and Finasteride Vs Serenoa Repens in Male Androgenetic Alopecia: A Two-Year Study. International Journal of Immunopathology and Pharmacology, 25 (4), 1167–1173. doi: http://doi.org/10.1177/039463201202500435
Semwal, D., Kotiyal, R., Chauhan, A., Mishra, A., Adhikari, L., Semalty, A., Semalty, A. (2015). Alopecia and the herbal drugs: an overview of the current status / Advances in Biomedicine and Pharmacy, 2 (6), 246–254. doi: http://doi.org/10.19046/abp.v02i06.01
Suchonwanit, P., Thammarucha, S., Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: a review. Drug Design, Developent and Therapy, 13, 2777–2786. doi: http://doi.org/10.2147/dddt.s214907
Motofei, I. G., Rowland, D. L., Baconi, D. L., Tampa, M., Sârbu, M.-I., Păunică, S. et. al. (2018). Androgenetic alopecia; drug safety and therapeutic strategies. Expert Opinion on Drug Safety, 17 (4), 407–412. doi: http://doi.org/10.1080/14740338.2018.1430765
Wessagowit, V., Tangjaturonrusamee, C., Kootiratrakarn, T., Bunnag, T., Pimonrat, T., Muangdang, N., Pichai, P. (2015). Treatment of male androgenetic alopecia with topical products containingSerenoa repensextract. Australasian Journal of Dermatology, 57 (3), e76–e82. doi: http://doi.org/10.1111/ajd.12352
Krishna, P. M., Rao, K. N. V., Sandhya, S., Banji, D. (2012). A review on phytochemical, ethnomedical and pharmacological studies on genus Sophora, Fabaceae. Revista Brasileira de Farmacognosia, 22 (5), 1145–1154. doi: http://doi.org/10.1590/s0102-695x2012005000043
Phad, A. R., Dilip, N. T., Ganapathy, R. S. (2018). Emulgel: a comprehensive review for topical delivery of hydrophobic drugs. Asian Journal of Pharmaceutics, 12 (2), 382–393. doi: http://dx.doi.org/10.22377/ajp.v12i02.2366
Yarema, I., Fedorovska, M. (2014). Development of the emulsion base composition when creating the medicinal cosmetic product used in androgenetic alopecia. News of Pharmacy, 2 (78), 15–19. doi: http://doi.org/10.24959/nphj.14.1938
Yarema, I. O., Fedorovska, M. I., Kutsyk, R. V. (2016). Substantiation of antibacterial preservatives choice in remedies for androgenic alopecia topical treatment. Odes’kij medicnij zurnal, 2 (154), 20–24.
Lanigan, R. S., Yamarik, T. A. (2002). Final Report on the Safety Assessment of BHT. International Journal of Toxicology, 21 (2), 19–94. doi: http://doi.org/10.1080/10915810290096513
State Standard of Ukraine (2008) No. 4765: 2007 Cosmetic creams. General technical conditions. State Consumer Standard of Ukraine. Kyiv.
Estanqueiro, M., Conceição, J., Amaral, M. H., Santos, D., Silva, J. B., Lobo, J. M. S. (2014). Characterization and stability studies of emulsion systems containing pumice. Brazilian Journal of Pharmaceutical Sciences, 50 (2), 361–369. doi: http://doi.org/10.1590/s1984-82502014000200016
Strus, O., Polovko, N., Yezerska, O. (2019). Justification of technological parameters of the cream production with sapropel extract. Pharmacia, 66 (1), 19–25. doi: http://doi.org/10.3897/pharmacia.66.e35022
Derzhavna Farmakopeia Ukrainy. Vol. 1 (2015). Kharkiv: Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv», 1128.
Fedorovska, M., Polovko, N. (2016). Development of the composition of the gel base for treating telogen effluvium. News of Pharmacy, 4 (88), 38–42. doi: http://doi.org/10.24959/nphj.16.2097
Fedorovska, M. I., Yarema, I. O. (2015). Technology development of herbal remedies for androgenic alopecia external application. The Pharma Innovation Journal, 4 (8), 26–28.
Shpychak, O., Tikhanov, A., Musoev, S. (2014). Тhe biopharmaceutical research of "protabent" ointmentin the experiments "in vitro". Bulletin of the Tajik National University. Series Medicine – Pharmacy, 1 (2 (130)), 217–221.
Mohsin, S., Akhtar, N., Mahmood, T., Khan, H., Mustafa, R. (2016). Formulation and stability of topical water in oil emulsion containing corn silk extract. Tropical Journal of Pharmaceutical Research, 15 (6), 1115–1121. doi: http://dx.doi.org/10.4314/tjpr.v15i6.1
Copyright (c) 2020 Inna Yarema
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.